Biological products, (no diagnostic substances) company · NV · FY ends Apr · Revenue $0.00
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$0.00
Net Income (TTM)
-$3M
▲ +9085.0% YoY
Op. Margin
—
ROIC
-10.08%
▲ +4.7pp YoY
Cash Flow & Balance Sheet
FCF
N/A
Op. Cash Flow (TTM)
-$5M
▼ -38.4% YoY
Net Debt
-$21M
Net Cash Position
Cash & Equiv.
$21M
Continue Research